Superficial gyrate erythema as a cutaneous reaction to alendronate for osteoporosis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 12789190.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alendronate is a bisphosphonate compound used to treat diseases of pathologic bone resorption. Cutaneous reactions to this medication are rare. We report the case of a superficial gyrate erythema that occurred as a reaction to weekly alendronate therapy used in the treatment of postmenopausal osteoporosis.
Medical subject headings
- Alendronate
- Erythema